![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 40, 37456-37463, October 4, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
, and
From the
Department of Microbiology, Stockholm
University, S-10691 Stockholm, Sweden and the § Department
of Bacteriology, University of Wisconsin,
Madison, Wisconsin 53706
Received for publication, July 14, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Regulation of RNA polymerase during initiation,
elongation, and termination of transcription is mediated in part by
interactions with intrinsic regulatory signals encoded in the RNA and
DNA that contact the enzyme. These interactions include contacts to an 8-9-bp RNA:DNA hybrid within the active-site cleft of the enzyme, contacts to the melted nontemplate DNA strand in the vicinity of the
hybrid, contacts to exiting RNA upstream of the hybrid, and contacts to
~20 bp of duplex DNA downstream of the active site. Based on
characterization of an amino acid substitution (G1161R) and a deletion
( Cellular, multisubunit RNA polymerases
(RNAPs)1 participate in a
complex cycle of conformational changes to initiate, elongate, and
terminate RNA transcripts. Each step in this cycle is mediated by a
network of protein-nucleic acid interactions composed of interconnected
parts of RNAP that contact DNA and product RNA (1-9). During
elongation, most nucleic acid contacts are made by two large subunits
of similar structure and sequence in prokaryotic and eukaryotic RNAPs,
called In both initiation and elongation complexes, a key component in this
protein-nucleic acid interaction network occurs between ~20 bp of
duplex DNA downstream of the polymerization site and a channel in RNAP
composed of a trough formed mostly by The downstream DNA interaction, which stretches from the position of
duplex melting 1-3 nt in front of the catalytic center to ~20 bp
further downstream, can be subdivided into active-site proximal and
active-site distal sets of contacts (Fig.
1, B and C). The
active-site proximal set of contacts is made at +5 to +8 by the lobe
and domain called the clamp (formed mostly by
1149-1190) in the jaw domain of the bacterial RNA polymerase
largest subunit (
'), we report here that contacts of the jaw domain
to downstream DNA at the leading edge of the transcription complex
contribute to regulation during all three phases of transcription. The
results provide insight into the role of the jaw domain-downstream DNA
contact in transcriptional initiation and pausing and suggest
possible explanations for the previously reported isolation of the jaw
mutants based on reduced ColEI plasmid replication.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
' and
in bacteria or RPB1 and RPB2 in eukaryotes. During
initiation, these contacts are supplemented by sequence-specific DNA
contacts made by auxiliary initiation factors (
in bacteria) that
mediate promoter engagement.
'(RPB1) and a cover formed by
the lobe domain of
(RPB2). During promoter engagement, establishment
of this contact is coupled to formation of the ~15 bp melted
transcription bubble and insertion of the template DNA strand into the
active site of RNAP (Refs. 1 and 10, and references therein). Upon
promoter escape, when RNAP forms a transcription elongation complex
(TEC), the downstream contact persists and participates in the response
of RNAP to pause, arrest, and termination signals (11-16).
'), both of which can
move relative to the central core of the enzyme (2, 8, 9). The
active-site distal set of contacts is made at +10 to +20 by the clamp
and by another feature termed the jaw. In eukaryotic RNAPII, the jaw is
extensive and includes an external domain of RBP1 and part of the RPB5
subunit, neither of which are present in bacterial RNAP. In bacterial
RNAP, the jaw contact involves only a C-terminal segment of
'. Both
major groove and backbone contacts are involved in the downstream DNA interaction of RNAP (7, 9), but it seems likely they will be largely
sequence-nonspecific to ensure facile translocation of the duplex
during transcription.

View larger version (78K):
[in a new window]
Fig. 1.
Location of
' alterations relative to RNAP
structure and downstream DNA duplex. A, location of
'G1161R and
'
(1149-1190). Conserved regions of
'
are shown in pink (A-H), with its structural
domains labeled (8, 49). SI indicates the position of a
187-aa sequence insertion in E. coli
' that is not
present in most bacterial species. The sequence of the E. coli
' subunit in the vicinity of the alterations
(Ec, top) is aligned with the corresponding
'
sequence from Thermus aquaticus (Ta,
bottom; the source of the bacterial RNAP crystal structure;
Ref. 49). Lines and italicized letters
above the amino acid sequences indicate positions of insertions in
various organisms (from left to right: a1, 32 aa in
Aquafex aeolicus; a2, 21 aa in A. aeolicus; euk., 155 and 162 aa in yeast and human
RNAPII, respectively (the eukaryotic jaw domain); c, 16 aa
in Corynebacterium glutamicum; and m, 11 aa in
Mycobacterium tuberculosis and Mycobacterium
leprae. B, the crystal structure of T. aquaticus RNAP (49) with relevant features labeled and the surface
affected by
'
(1149-1190) colored magenta.
C, a model of the bacterial TEC with the clamp domain
rotated to match the position observed in the yeast RNAPII crystal
structure (9). The downstream DNA duplex is numbered based on TEC
convention, with +1 being the first base downstream of the active site
(the 3' nt is assumed to be in the NTP-binding or i+1
subsite of the active site; Refs. 3 and 9). This is equivalent to the
+3 position in an open complex, which by convention is indexed with +1
in the priming or i subsite of the active site.
D, close-up of the jaw domain with
'1149-1190 shown as a
magenta worm and the location of Gly-1161 shown
in green. E and F, surfaces of
wild-type and
'
(1149-1190) RNAPs color-coded by surface charge
potential (scheme shown below). The view is the same as in
D; the DNA is rendered semitransparent.
Ederth et al. (17) recently reported that a deletion
(
1149-1190) or a single amino acid substitution (G1161R) in the
portion of the Escherichia coli RNAP
' subunit that forms
the bacterial jaw domain dramatically reduces the copy number of
ColEI-type plasmids. They propose that these changes alter the relative
activity of the promoters for the two RNA regulators of ColEI plasmid
replication, RNAII and RNAI. Because RNAII primes plasmid replication
and RNAI negatively regulates RNAII formation (18), a decrease in RNAII or an increase in RNAI would reduce plasmid copy number. Changes in
contacts of RNAP to downstream DNA appear able to reduce promoter activity by reducing the longevity of open complexes formed at certain
promoters (Refs. 19 and 20; see "Results"). Alternatively, it is
possible that changes in transcriptional elongation and pausing, which
are mediated in part by the downstream DNA contact, could alter the
folding pathway of RNAI or RNAII (21). To investigate these ideas
further and to test the role of the RNAP jaw-downstream DNA contact in
RNAP function, we purified RNAPs containing these alterations and
tested their effects on transcription initiation and elongation
in vitro using assays that reveal separate steps in the
transcription cycle.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Reagents and Proteins--
Oligonucleotides were obtained from
Operon Technologies (Alameda, CA); NTPs from Amersham
Biosciences; [
-32P]CTP and
[
-32P]UTP from PerkinElmer Life Sciences; and other
chemicals from Sigma. Wild-type and mutant RNAPs were purified
by chitin-affinity chromatography and intein-mediated removal of the
chitin-binding domain tag after overexpression from a T7 RNAP-based
expression plasmid, as described
elsewhere.2 To obtain
overexpression plasmids encoding
'G1161R and
'
(1149-1190), rpoC fragments containing these mutations were PCR-amplified
from strains JE1134 or JE221 (17) using oligonucleotides 101E and 102E
(Table I), digested with SalI and BspEI, and then
ligated into SalI, BspEI-cut pRL663, which
expresses C-terminally His6-tagged
' from a
lacI-regulated trc promoter (22). The mutant
rpoC genes were then transferred to the RNAP overexpression
plasmid pIA4232 on a BsmI to XhoI
fragment that is unique in both plasmids. Wild-type and mutant RNAP
holoenzymes (core
'
2 plus
70) were
prepared by incubating a 5-fold molar excess of
70 with
core enzyme for 30 min at 30 °C.
70 was purified as
described previously (23).
DNA Templates-- DNA templates were either PCR products amplified from plasmid DNA or supercoiled plasmid DNA, as described in the figure legends (plasmids, PCR primers, and templates are listed in Table I). Linear templates for in vitro transcription were generated by PCR amplification and purified using QIAspin PCR purification reagents (Qiagen, Valencia, CA). Supercoiled plasmids were isolated using the Qiagen midiprep reagents. DNA templates for open complex stability measurements (plasmids and primers for amplification of linear templates) were kindly provided by M. Barker and R. Gourse (University of Wisconsin, Madison).
Lifetimes of Open Complexes--
Lifetimes of open complexes
were measured on supercoiled plasmid DNA (rrnB P1 and RNAII)
or linear DNA templates (lacUV5 and
PR) using
single-round transcription assays (24). RNAP and template DNA were
incubated ~15 min at 30 °C in initiation buffer (40 mM
Tris·HCl, pH 8.0, 10 mM MgCl2, and 1 mM dithiothreitol) with different concentrations of NaCl
(rrnB P1, 7.5 mM; RNAII, 35 mM;
lacUV5, 100 mM;
PR, 150 mM). Aliquots (10 µl) were removed to a tube containing
1.5 µl of NTPs to yield final concentrations of 200 µM
ATP (1 mM ATP for the rrnB P1 promoter), 200 µM GTP, 200 µM CTP, and 10 µM
[
-32P]UTP (50 Ci/mmol) at different times after
heparin addition (10 µg/ml final concentration). Transcription was
stopped after 10 min by addition of an equal volume of formamide
loading buffer, and RNA samples were analyzed as described below.
Halted Complex Formation--
Elongation complexes were formed
with 40 nM linear DNA template and 50 nM RNAP
holoenzyme in 20-100 µl of transcription buffer (20 mM
Tris·HCl, 20 mM NaCl, 3 mM MgCl2,
14 mM 2-mercaptoethanol, 0.1 mM EDTA, pH 7.9).
On the T7 A1 promoter templates, elongation complexes were halted at
positions indicated in figure legends when transcription is initiated
in the absence of UTP, with ApU at 150 µM, ATP and GTP at
2.5 µM, [
-32P]CTP at 1 µM.
Halted complexes were formed for 15 min at 37 °C and stored on ice
prior to use.
Elongation Rate Assays-- Halted A29 complexes were formed on a linear DNA template containing a portion of the rpoB gene (Table I). Transcription was restarted by addition of NTPs to 40 µM each, and heparin to 50 µg/ml. Samples were combined at 5, 10, 15, 20, 30, 45, 60, 90, 120, 240, 480, and 600 s with an equal volume of stop buffer (10 M urea, 98 mM Tris borate, pH 8.3, 25 mM Na2EDTA, 0.05% bromphenol blue) and analyzed as described below.
|
Single Round Pause Assays-- Halted complexes were formed as described above in 50 µl of transcription buffer. Transcription was restarted by addition of nucleotides (ATP, CTP, and UTP to 150 µM; GTP to 10 µM) and heparin to 50 µg/ml. Samples were combined at times shown in the figures and after a final 5-min incubation with 250 µM each NTP (chase) with an equal volume of stop buffer and analyzed as described below.
Elongation Complex Stability Assays-- A29 complexes were formed on a linear DNA template (PCR-amplified fragment of pIA171) for 15 min at 37 °C. At time 0, KCl was added to a final concentration of 1 M, and samples were shifted to 45 °C to facilitate dissociation of the TECs. At increasing times (see Fig. 6), aliquots of the TEC were removed to 37 °C and transcription was restarted by addition of NTPs to 250 µM and heparin to 50 µg/ml. Following a 5-min incubation, reactions were quenched by the addition of an equal volume of stop buffer and analyzed as described below.
Termination Assays--
Halted
[
-32P]CTP-labeled A20 elongation complexes were
prepared as above in 20 µl of transcription buffer with 40 nM linear DNA template and 50 nM RNAP
holoenzymes containing
70. Elongation was started by
addition of NTPs to 400 µM each, KCl to 100 mM, and heparin to 25 µg/ml. Reactions were incubated at 37 °C for 15 min and stopped by addition of an equal volume of the
stop buffer.
RNA Analysis--
Samples were heated for 2 min at 90 °C and
separated by electrophoresis in denaturing 5-15% polyacrylamide gels
(19:1 acrylamide:bisacrylamide) in 7 M urea, 44 mM Tris borate, pH 8.3, 1.25 mM
Na2EDTA). Gels were dried, and the RNA products were
visualized and quantified using PhosphorImager screens and ImageQuant
Software (Amersham Biosciences). Pause half-life (time during
which half of the complexes re-enter the elongation pathway) and pause
efficiency (fraction of transcribing RNAP molecules that pause) were
determined by nonlinear regression analysis as described (25).
Termination efficiencies were calculated as described by Reynolds
et al. (15).
| |
RESULTS |
|---|
|
|
|---|
Jaw Mutant RNAPs Decrease Open Complex Longevity in Vitro--
We
began by testing a simple explanation for the finding that RNAII
promoter (PRNAII) activity decreases in the jaw deletion mutant, whereas PRNAI activity increases (17), namely that
the jaw mutants reduce the kinetic stability of open initiation
complexes. Although the detailed mechanism of open complex formation
involves at least three steps and can vary among promoters (10), it can be generalized as an initial, RNAP concentration-dependent
binding step to form closed complexes, which is rapid and characterized by an equilibrium constant KB, and subsequent
RNAP-concentration-independent isomerization steps to form open
complexes, which are characterized by composite rate constants
k2 and k
2 (Refs. 26 and
27; Reaction 1).
|
|
2 is fast relative to
k2 (making open complexes kinetically unstable),
the overall rate of initiation is sensitive to changes in
k
2, whereas when k
2
is slow relative to k2 (making kinetically
stable open complexes), the overall rate of initiation is insensitive
to changes in k
2, and can even increase
in vivo as a result of indirect effects (19, 28, 29). This
is true for two reasons. First, short-lived open complexes exist in a
dynamic competition between collapse back to the closed complex
versus NTP binding and productive initiation. An
increase in k
2 will shift the competition away
from productive initiation at these promoters while having little
effect on initiation at promoters for which open complexes are
long-lived relative to the time required for NTP binding and productive
initiation. Second, the majority of cellular transcription is mediated
by kinetically unstable open complexes formed at rRNA promoters. Thus,
factors that decrease transcription from rRNA promoters (e.g. by increasing k
2 generally)
also indirectly increase initiation at promoters that form long-lived
open complexes by increasing the pool of RNAP available for promoter
binding in cells (28, 29). Because downstream DNA contacts are known to
contribute to open complex longevity (19, 20) and because PRNAI is known to form kinetically stable open complexes
(24, 28-30), it is plausible that the RNAP jaw alterations could
reduce plasmid copy number by directly reducing PRNAII
activity and indirectly increasing PRNAI activity.
To test this possibility, we examined the kinetic stability of open
complexes formed at PRNAI, PRNAII, and three
additional, well studied promoters: rrnB P1, lac
UV5, and
PR. To measure open complex lifetimes, we
incubated pre-formed open complexes with heparin, which acts as a
competitor to trap free RNAP (31), and then added radiolabeled NTPs to
samples taken at increasing times to measure the fraction of complexes
still able to form a productive RNA transcript (Ref. 24; see
"Experimental Procedures"). The mutant RNAPs exhibited dramatically
decreased half-lives for PRNAII, rrnB P1,
lac UV5, and
PR, as reflected by rapid
disappearance of the ability to make RNA transcripts after addition of
heparin (by factors of 10-40; Fig. 2 and
Table II; note that the half-lives for
different promoters cannot be compared with each other directly because
the conditions differ among assays). In contrast, the longevity of open
complexes formed at PRNAI was too long to measure, and thus
we were unable to determine whether the mutants also affected the
half-life of open complexes formed at this promoter (Fig. 2). However,
the persistence of open complexes at PRNAI provides a
useful control showing that the mutant RNAPs were fully active and did
not yield inherently defective open complexes; rather, the relatively
uniform 10-40-fold effect on k
2 of the jaw
mutants likely fails to increase k
2 at
PRNAI to a range that can be measured.
|
|
We conclude that altering the downstream DNA jaw of RNAP dramatically
reduces open complex longevity at several promoters. In principle, this
could result either from a decrease in the thermodynamic stability of
open complexes or a decrease in the activation barrier between open and
closed complexes. The latter effect, however, would also increase the
rate of open complex formation (k2) and
counteract reduced initiation caused by increasing k
2. Because the jaw alterations were found to
decrease transcription from PRNAII in vivo (17),
the most reasonable interpretation of our results is that the jaw
domain of bacterial RNAPs makes a contact to downstream DNA that
stabilizes the open complex.
Jaw Mutant RNAPs Exhibit an Increased Elongation Rate--
It also
is possible that the jaw mutants affect elongation by RNAP and that
changes in transcript elongation cause or contribute to lowered ColE1
plasmid copy number. Downstream DNA contacts are known to influence
pausing by RNAP (11, 13, 32, 33) and the pattern or extent of pausing
could influence folding or interaction of RNAI and RNAII (21), which is
the central event in the inhibition of replication primer formation by
RNAI (18). To ask how jaw alterations affect the activities of the TEC,
we first tested their effects on the overall rate of transcript
elongation. We formed initially halted TECs (at position 29 by
withholding UTP during initiation) on a template that specified a
fragment of the E. coli rpoB gene downstream from the halt
site (see "Experimental Procedures"). Upon adjustment of all four
NTP concentrations to 40 µM each, wild-type and mutant
RNAPs resumed elongation and formed a run-off transcript in less than 1 min. However,
'
(1141-1190) RNAP reached the template end
approximately twice as fast as wild type (half the TECs completed the
run-off transcript in ~20 s, rather than ~40 s for wild type).
'GR1161 exhibited a much less dramatic increase in elongation rate.
The increased elongation rate of
'(1141-1190) RNAP was reflected in
a decrease in pausing at several prominent sites within the
rpoB gene (Fig. 3A,
arrows). We concluded that the downstream jaw contact of
bacterial RNAP is partially responsible for recognition of
transcriptional pause sites. Thus, reduced pausing and consequent
effects on RNA folding also might influence the competition between
RNAI-RNAII interaction and replication primer formation in ColEI
plasmids.
|
Jaw Mutant RNAPs Were Defective in Two Types of Transcriptional Pausing-- To investigate the role of the jaw domain in transcriptional pausing further, we tested examples of two classes of pause signals: the class I his leader pause signal, for which escape from the paused state is inhibited by RNA secondary structure called a pause hairpin, and the class II pheP ops pause signal, for which escape from the paused state is inhibited by backtracking of RNAP along the RNA and DNA chains (34). Both types of pausing occur in a two-step mechanism: isomerization to the paused state in competition with elongation past the site, followed by slow escape from the paused state. For the class I his pause, the downstream DNA sequence, as well as the RNA:DNA hybrid region and the bases in the active site, influence both steps (22); these three components plus the pause hairpin additively delay escape from the pause state by nucleotide addition (32, 33). The determinants of the class II ops pause have not been analyzed. However, by analogy to the class II human immunodeficiency virus type 1 pause signal that affects human RNAPII, they include the thermodynamic stability of the RNA:DNA hybrid in the active conformation of the TEC, the hybrid stability in the backtracked TEC that forms at the pause site (35, 36), and the sequence of the downstream DNA.3
We found that deletion of the
' jaw decreased pausing at both
classes of pause signals, whereas the G1161R substitution had less
effect (Figs. 4 and
5). Interestingly, the deletion decreased both the efficiency and half-life of pausing at both classes of pause
signal. However, the magnitude of these effects differed. Whereas the
deletion decreased half-life and efficiency by factors of 3 and 4, respectively, at the class II ops signal, it decreased half-life by a factor of 6 at the class I his pause signal
while decreasing efficiency by only a factor of 1.5. We conclude that the
' jaw plays a positive role in recognition of both classes of
pause signal and in stabilizing both types of paused conformation, most
likely through an interaction with the downstream DNA duplex. This is
consistent with current models of transcriptional pausing (see
"Discussion") and with the possibility that changes in RNAI-RNAII interaction mediated by transcriptional pausing could contribute to the
plasmid copy number phenotype of the mutant RNAPs.
|
|
Pausing also is an initial step in transcriptional termination at
-independent terminators (37, 38). To ask whether the
'
(1149-1190) RNAP would manifest a defect in transcriptional termination as a result of its defect in pausing, we tested the effect
of the deletion on readthrough of the T7 terminator, which has
previously been found to require a downstream DNA interaction for
efficient termination in vitro (12). We found that the
deletion increased readthrough of the T7 terminator from 10 to 20%,
relative to wild type, under transcription conditions similar to those of Figs. 4 and 5 (data not shown; see "Experimental
Procedures").
Jaw Mutant RNAPs Exhibit Lesser Effects on TEC Stability and Abortive Initiation-- A possible explanation for some of the in vitro phenotypes we observed for the jaw deletion RNAP would be a change in the affinity of RNAP for the nucleic acid scaffold (although decreased termination would suggest an increased affinity, whereas decreased open complex longevity would suggest a decreased affinity). To test directly for simple changes in affinity for either the DNA or RNA, we examined the effect of the deletion on the thermal stability of TEC and on abortive initiation. If the jaw deletion RNAP lost affinity for the nucleic acid scaffold in a TEC, we would expect an increase in the rate of thermal inactivation of TECs. If the jaw deletion RNAP lost affinity for the RNA product, we would expect an increase in the rate of abortive initiation.
We tested the stability of TECs, by making halted A29 complexes on the
his pause template (shown in Fig. 4) and challenging them
with high salt (1 M KCl) and high temperature (45 °C).
Both the jaw deletion RNAP and
'G1161R RNAP exhibited a slightly
shorter TEC half-life compared with the wild type (reduced by a factor of 1.5 at most; Fig. 6). This TEC
inactivation could result either from dissociation of the TEC or from
backtracking into an arrested state (35, 39, 40). In either case, the
result suggests only a minor thermal instability of the mutant RNAPs
themselves or of their interactions with the nucleic-acid scaffold, but
not of the magnitude that could explain their effects on open complex longevity or transcriptional pausing.
|
We compared the ratio of abortive to productive RNA products during A29
complex formation in experiments such as those shown in Figs. 4 and 5.
We found that neither RNAP exhibited an altered abortive/productive RNA
ratio (data not shown), suggesting that the
' jaw does not influence
the affinity of RNAP for the RNA product, consistent with its predicted
interaction exclusively with the downstream DNA in transcription complexes.
We conclude that the
' jaw contributes slightly to the
stability of TECs through interactions with DNA. However, the major effects that the jaw deletion manifests on open complex longevity and
transcriptional pausing do not appear to be simple consequences of
weakened affinity for the nucleic acid scaffold in transcription complexes. Rather, the contact of the jaw to the downstream DNA is
likely to affect the rates of kinetic transitions in transcription complexes that are important for open complex longevity and pausing during transcript elongation.
| |
DISCUSSION |
|---|
|
|
|---|
Our chief conclusions are that the
' jaw of bacterial RNAP
plays a significant role in both open complex longevity and in transcriptional pausing. These findings are consistent with recent ideas about the role of the downstream DNA duplex in these processes, as well as molecular modeling that suggests the downstream DNA interacts with the
' jaw in both open complexes and TECs.
Interaction of the Downstream DNA Duplex with the
' Jaw of
RNAP--
The path of the downstream DNA duplex in both open
initiation complexes and TECs formed by E. coli RNAP has
been modeled based on cross-linking and fluorescence resonance energy
transfer analyses of the position of the phosphate backbone relative to
segments of the
and
' subunits (41-43). These models offer a
generally consistent picture in which duplex DNA enters RNAP between
flexible regions of
and
' termed the lobe and clamp in a trough
formed mostly by
' (see Introduction and Fig. 1 (B and
C)). This positioning of the downstream DNA duplex also is
consistent with the weak electron density observed for the downstream
DNA duplex in the x-ray diffraction pattern of an RNAPII TEC crystal
(9).
The jaw deletion removes a segment of
' near the DNA duplex from
~10 to ~20 bp downstream of the active site, with the jaw itself
being closest to a segment from +15 to +20 (Fig. 1, C and D). The sequence in this region folds into a three-stranded
antiparallel
-sheet that cross-links to the nontemplate DNA strand
near +15 (3), is variable in sequence among bacterial RNAPs (Fig.
1A), and lies near an insertion of 187 aa that is present
only in some bacteria (44). Gly-1161, however, is invariant among
bacterial RNAPs and occurs at a turn leading to the first
strand.
Given this high conservation and the known structural role of Gly
residues in protein loops (45), we postulate that the G1161R
substitution disrupts the structure of the bacterial jaw. The region
removed by the jaw deletion is nearly neutral (7 each acidic and basic residues in the E. coli
'(1149-1190); 9 acidic and 7 basic residues in the corresponding T. aquaticus segment
depicted in Fig. 1 (B-F)). However, the basic residues
mostly line the DNA entry channel whereas the acidic residues mostly
face away from the nucleic acid path, yielding a net positive charge in
part of the channel affected by the deletion (Fig. 1, D and
E). The deletion may remove principally ionic contacts to
the DNA phosphodiester backbone in the +5 to +15 region (Fig.
1F). However, we cannot exclude the possibility that this
segment of the DNA entry channel also makes sequence-nonspecific,
hydrophobic contacts to bases in the downstream duplex, as proposed for
the more extensive jaw region of RNAPII (7).
Role of Downstream DNA Interaction in Open Complex
Longevity--
The conversion of bacterial RNAP from a closed to an
open initiation complex is accompanied by extension of its DNA contacts from +1 to +20, a transition proposed to correspond to insertion of the
downstream DNA duplex into the DNA entry channel and concomitant unwinding of the duplex in the vicinity of the active site (4, 10).
Once the open complex has formed, the downstream duplex lies near the
' jaw as described in the preceding section (41, 43). Either
disruption of the jaw structure by the G1161R substitution or removal
of the jaw by the
'(1149-1190) deletion appears to reduce the
stability of the open complexes, so that the downstream duplex more
readily falls out of the entry channel.
The importance of the jaw-DNA contact for transcriptional regulation is
underscored by its apparent targeting by the T7 phage transcriptional
inhibitor gp2. Substitutions in the jaw (E1158K and E1188K) prevent
binding by gp2, as does
'
(1148-1198) (46). gp2 blocks open
complex formation by E
70 holoenzyme at
35-element-dependent promoters, but not at
35-element-independent promoters (so-called extended
10 promoters).
This led Nechaev and Severinov (46) to propose that gp2 directly or
indirectly blocks binding of sigma region 4.2 to the
35 promoter
element. Our finding that the jaw region contributes to open complex
longevity suggests an alternative interpretation for the effect of gp2
on
35-dependent promoters. Promoters dependent on the
35 sequence may be poised near a balance point of open complex
stability because they lack the stabilizing interaction of sigma region
3.0 with the extended
10 sequence (5, 47). In the equilibrium between open complexes with DNA bound in the downstream channel
versus closed complexes with gp2 bound in the channel,
promoters lacking the extended
10 may lack the energy required to
displace gp2 and form open complexes. Thus, gp2 binding to the jaw may
simply tip the scales against a near even balance of open complex
versus closed complex at
35-element dependent promoters,
but have little effect on extended
10 promoters where open complex
formation is more strongly favored.
It is unclear whether the decrease in longevity of PRNAII
open complexes alone is sufficient to account for the entire ~4-fold shift in PRNAI/PRNAII activity caused by the
jaw alterations in vivo (17). The PRNAII
k
2 observed for
'
(1141-1190) RNAP
(~10
2 s
1) is still at least 300 times
slower than the wild-type k
2 for
rrnB P1 (Table II), at which a 4-30-fold increase in
k
2 abrogates growth rate control of
rrnB P1 initiation that is mediated by short-lived open
complexes (48). It also is too slow to be on the same time scale of
initiation, which would preclude direct effects of short-lived open
complexes on RNAII synthesis. It is possible that other factors
in vivo decrease the longevity of PRNAII open
complexes to this time scale or that principal effects of the jaw
alterations on the more short-lived rrn open complexes affect RNAI/RNAII indirectly by increasing the concentration of free
RNAP in the cell (19, 28). It is also possible that the loss of
jaw-downstream DNA interaction affects steps in open complex formation
other than just open complex longevity. Further work will be necessary
to assign the cause of altered RNAI/RNAII transcription definitively;
our primary finding here is that the jaw-DNA contact is an important
contributor to open complex longevity.
Role of Downstream DNA Interaction in Transcriptional
Pausing--
We found that alterations to the
' jaw suppressed both
recognition of and escape from two different classes of pause signals by RNA polymerase (Figs. 5 and 6). Current models for transcriptional pausing posit an initial isomerization to an unactivated state that
competes with nucleotide addition at the pause site (34, 36). This
unactivated (or initially paused) state can be stabilized by
interactions that slow re-establishment of the reactive alignment of
nucleotides in the active site, including interaction of an RNA
secondary structure with the RNA exit channel of RNAP (class I pause),
or backtracking of the unactivated TEC along the RNA and DNA chains
(class II pause). Our current findings strongly suggest that
interactions of downstream DNA with the jaw may both stabilize the
paused RNAP against reformation of the active state (as reflected in
the effect on pause half-life), and promote isomerization to the
initially paused (unactivated) intermediate (as reflected by the effect
on pause efficiency), thereby affecting both classes of transcriptional pausing.
How the downstream DNA exerts its effect on pausing (as well as on
termination and arrest) remains an important question. The effect on
pausing is known to depend on a characteristic of the downstream duplex
other than its ease of melting and to extend to ~15 bp downstream of
the pause site (13). However, the precise sequence determinants of this
effect and the positions within the ~15 bp downstream DNA duplex that
are critical for it have not been elucidated. Our current results add
three important pieces of information to this subject, which
nevertheless will require additional study for a full understanding.
First, at least part of the downstream DNA effect is mediated by
contacts of the +5 to +15 region to the jaw domain. Second, the
contribution of this downstream DNA contact to pausing may be partly
steric, rather than dependent on side chain-base interactions, because
removal of the jaw by
'
(1149-1190) suppressed
pausing more effectively than disruption of its structure by
'G1161R
(in contrast to their effects on open complex longevity). If the effect
of downstream DNA on pausing depends on its structural distortion, for
instance bending, as was suggested for its effects on termination and
arrest (12, 14), then the absence of the jaw in the deletion may interfere with this effect more than does the disrupted jaw structure of the G1161R substitution. Third, the downstream contact (at least in
the +5 to +15 region) appears to favor pausing rather than elongation
because removal of the contact in the jaw deletion RNAP suppresses
pausing, the opposite of what would be expected if pausing was
accompanied by loss of a downstream contact that ordinarily favored
nucleotide addition.
Conclusion--
Taken together, our results define an important
component of the network of RNAP-nucleic acid interactions that
regulates transcription: the jaw-downstream DNA contact. Effects of
this contact on both initiation and elongation may contribute to the reduction in plasmid copy number caused by
'
(1149-1190) than
'G1161R. The effects on initiation are especially interesting because altered transcription as a consequence of destabilizing open
complexes is the proposed mechanism of the bacterial stringent response. In that case, ppGpp, by destabilizing open complexes, redistributes RNAP from promoters that form short-lived open complexes to promoters that form long-lived open complexes (19, 28, 29).
Interestingly, however, neither
'
(1149-1190) nor
'G1161R suppress the multiple amino acid auxotrophy of so-called
ppGpp0 strains,4
which is a hallmark of previously characterized mutant RNAPs that
decrease open complex half-life (20). Future studies will address
whether the sensitive plasmid copy number selection used to isolate
'
(1149-1190) and
'G1161R yielded mutants with weaker effects,
or whether the role of the
' jaw-downstream DNA interaction in open
complex formation exhibits special features.
| |
ACKNOWLEDGEMENTS |
|---|
We thank M. Barker and T. Gaal for much assistance and many useful discussions during the course of these experiments, R. Gourse for gift of plasmid and oligonucleotide samples, and R. Gourse and K. Geszvain for helpful comments on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant GM 38660 (to R. L.), grants from the Swedish National Research Council and the Swedish Research Council (to L. A. I.), and a grant from the Wallenberg Foundation (to J. E.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Present address: Dept. of Microbiology, Ohio State University, Columbus, OH 43210.
To whom correspondence should be addressed. Fax:
608-262-9865; E-mail: landick@bact.wisc.edu.
Published, JBC Papers in Press, July 29, 2002, DOI 10.1074/jbc.M207038200
2 I. Artsimovitch, V. Svetlov, K. S. Murakami, and R. Landick, manuscript in preparation.
3 M. Palangat, personal communication.
4 J. Ederth, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: RNAP, RNA polymerase; TEC, transcription elongation complex; nt, nucleotide(s); aa, amino acid(s).
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Craig, M. L., Tsodikov, O. V., McQuade, K. L., Schlax, P. E., Jr., Capp, M. W., Saecker, R. M., and Record, M. T., Jr. (1998) J. Mol. Biol. 283, 741-756[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Darst, S. A.,
Opalka, N.,
Chacon, P.,
Polyakov, A.,
Richter, C.,
Zhang, G.,
and Wriggers, W.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
4296-4301 |
| 3. |
Korzheva, N.,
Mustaev, A.,
Kozlov, M.,
Malhotra, A.,
Nikiforov, V.,
Goldfarb, A.,
and Darst, S. A.
(2000)
Science
289,
619-625 |
| 4. |
Murakami, K. S.,
Masuda, S.,
Campbell, E. A.,
Muzzin, O.,
and Darst, S.
(2002)
Science
296,
1285-1290 |
| 5. |
Murakami, K. S.,
Masuda, S.,
and Darst, S.
(2002)
Science
296,
1280-1284 |
| 6. | Landick, R. (2001) Cell 105, 567-570[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Cramer, P.,
Bushnell, D., Fu, J.,
Gnatt, A.,
Maier-Davis, B.,
Thompson, N.,
Burgess, R.,
Edwards, A.,
David, P.,
and Kornberg, R.
(2000)
Science
288,
640-649 |
| 8. |
Cramer, P.,
Bushnell, D.,
and Kornberg, R.
(2001)
Science
292,
1863-1876 |
| 9. |
Gnatt, A.,
Cramer, P., Fu, J.,
Bushnell, D.,
and Kornberg, R. D.
(2001)
Science
292,
1876-1882 |
| 10. | Saecker, R., Tsodikov, O., McQuade, K., Schlax, P., Jr., Capp, M., and Record, M., Jr. (2002) J. Mol. Biol. 319, 649-671[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
LaFlamme, S. E.,
Kramer, F. R.,
and Mills, D. R.
(1985)
Nucleic Acids Res.
13,
8425-8440 |
| 12. | Telesnitsky, A., and Chamberlin, M. (1989) Biochemistry 28, 5210-5218[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Lee, D. N.,
Phung, L.,
Stewart, J.,
and Landick, R.
(1990)
J. Biol. Chem.
265,
15145-15153 |
| 14. | Kerppola, T. K., and Kane, C. M. (1990) Biochemistry 29, 269-278[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Reynolds, R., Bermúdez-Cruz, R. M., and Chamberlin, M. J. (1992) J. Mol. Biol. 224, 31-51[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Keene, R. G.,
Mueller, A.,
Landick, R.,
and London, L.
(1999)
Nucleic Acids Res.
27,
3173-3182 |
| 17. | Ederth, J., Isaksson, L., and Abdulkarim, F. (2002) Mol. Genet. Genomics 267, 587-592[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Tomizawa, J. (1990) J. Mol. Biol. 212, 683-694[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Barker, M. M., Gaal, T., and Gourse, R. L. (2001) J. Mol. Biol. 305, 689-702[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Bartlett, M. S., Gaal, T., Ross, W., and Gourse, R. L. (1998) J. Mol. Biol. 279, 331-345[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Pan, T.,
Artsimovitch, I.,
Fang, X. W.,
Landick, R.,
and Sosnick, T. R.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9545-9550 |
| 22. | Wang, D., Meier, T., Chan, C., Feng, G., Lee, D., and Landick, R. (1995) Cell 81, 341-350[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Gribskov, M., and Burgess, R. R. (1983) Gene (Amst.) 26, 109-118[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Leirmo, S., and Gourse, R. L. (1991) J. Mol. Biol. 220, 555-568[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Landick, R., Wang, D., and Chan, C. (1996) Methods Enzymol. 274, 334-352[Medline] [Order article via Infotrieve] |
| 26. | Chamberlin, M. J. (1974) Annu. Rev. Biochem. 43, 721-775[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | McClure, W. R. (1985) Annu. Rev. Biochem. 54, 171-204[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Zhou, Y. N.,
and Jin, D. J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2908-2913 |
| 29. | Barker, M. M., Gaal, T., Josaitis, C. A., and Gourse, R. L. (2001) J. Mol. Biol. 305, 673-688[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Gaal, T.,
Bartlett, M.,
Ross, W.,
Turnbough, C., Jr.,
and Gourse, R.
(1997)
Science
278,
2092-2097 |
| 31. |
Pfeffer, S. R.,
Stahl, S. J.,
and Chamberlin, M. J.
(1977)
J. Biol. Chem.
252,
5403-5407 |
| 32. | Chan, C. L., and Landick, R. (1993) J. Mol. Biol. 233, 25-42[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Chan, C., Wang, D., and Landick, R. (1997) J. Mol. Biol. 268, 54-68[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Artsimovitch, I.,
and Landick, R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
7090-7095 |
| 35. | Nudler, E., Mustaev, A., Lukhtanov, E., and Goldfarb, A. (1997) Cell 89, 33-41[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Palangat, M., and Landick, R. (2001) J. Mol. Biol. 311, 265-282[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
McDowell, J. C.,
Roberts, J. W.,
Jin, D. J.,
and Gross, C.
(1994)
Science
266,
822-825 |
| 38. | Gusarov, I., and Nudler, E. (1999) Mol. Cell 3, 495-504[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Komissarova, N.,
and Kashlev, M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1755-1760 |
| 40. |
Komissarova, N.,
and Kashlev, M.
(1997)
J. Biol. Chem.
272,
15329-15338 |
| 41. | Naryshkin, N., Revyakin, A., Kim, Y., Mekler, V., and Ebright, R. H. (2000) Cell 101, 601-611[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Korzheva, N., Mustaev, A., Nudler, E., Nikiforov, V., and Goldfarb, A. (1998) Cold Spring Harbor Symp. Quant. Biol. 63, 337-345[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Mekler, V., Kortkhonjia, E., Mukhopadhyay, J., Knight, J., Revyakin, A., Kapanidis, A. N., Niu, W., Ebright, Y. W., Levy, R., and Ebright, R. H. (2002) Cell 108, 599-614[CrossRef][Medline] [Order article via Infotrieve] |
| 44. |
Zakharova, N.,
Bass, I.,
Arsenieva, E.,
Nikiforov, V.,
and Severinov, K.
(1998)
J. Biol. Chem.
273,
24912-24920 |
| 45. | Geetha, V., and Munson, P. J. (1997) Protein Sci. 6, 2538-2547[Abstract] |
| 46. | Nechaev, S., and Severinov, K. (1999) J. Mol. Biol. 289, 815-826[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | Barne, K. A., Bown, J. A., Busby, S. J., and Minchin, S. D. (1997) EMBO J. 16, 4034-4040[CrossRef][Medline] [Order article via Infotrieve] |
| 48. |
Barker, M. M.,
and Gourse, R. L.
(2001)
J. Bacteriol.
183,
6315-6323 |
| 49. | Zhang, G., Campbell, E. A., Minakhin, L., Richter, C., Severinov, K., and Darst, S. A. (1999) Cell 98, 811-824[CrossRef][Medline] [Order article via Infotrieve] |
| 50. | Ross, W., Thompson, J. F., Newlands, J. T., and Gourse, R. L. (1990) EMBO J. 9, 3733-3742[Medline] [Order article via Infotrieve] |
| 51. |
Chan, C.,
and Landick, R.
(1989)
J. Biol. Chem.
264,
20796-20804 |
| 52. | Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Methods Enzymol. 185, 60-89[Medline] [Order article via Infotrieve] .0 |